SPDR S&P Biotech ETF (XBI)
AMEX: XBI
· Real-Time Price · USD
82.64
0.54 (0.66%)
At close: Jun 18, 2025, 3:59 PM
82.30
-0.41%
After-hours: Jun 18, 2025, 07:57 PM EDT
0.66% (1D)
| Bid | 81.5 |
| Market Cap | 4.57B |
| AUM | 4.68B |
| NAV | 82.1 |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Shares Out | 55.35M |
| Inception Date | Jan 30, 2006 |
| Ask | 82.87 |
| Volume | 8.67M |
| Open | 82.27 |
| Previous Close | 82.10 |
| Day's Range | 81.53 - 83.42 |
| 52-Week Range | 66.66 - 105.47 |
| Holdings | 127 |
| Expense Ratio | 0.35% |
About XBI
The SPDR S&P Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select IndustryTM Index (the “Index”)Seeks to provide exposure to the Biotechnology segment of the S&P TMI, which comprises the following sub-industries: BiotechnologySeeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocksAllows investors to take strategic or tactical positions at a more targeted level than traditional sector based investing
Asset Class Equity
Ticker Symbol XBI
Inception Date Jan 30, 2006
Provider State Street
Website Fund Home Page
Exchange AMEX
Top 10 Holdings 27.76% of assets
| Name | Symbol | Weight |
|---|---|---|
| Insmed Incorporated | INSM | 3.35% |
| Alnylam Pharmaceutic... | ALNY | 3.19% |
| Blueprint Medicines ... | BPMC | 2.95% |
| Exact Sciences Corpo... | EXAS | 2.90% |
| Natera, Inc. | NTRA | 2.87% |
| Neurocrine Bioscienc... | NBIX | 2.86% |
| Incyte Corporation | INCY | 2.51% |
| Gilead Sciences, Inc... | GILD | 2.42% |
| Amgen Inc. | AMGN | 2.37% |
| Biogen Inc. | BIIB | 2.34% |
Dividends Dividend Yield 0.03%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Mar 24, 2025 | $0.0053 | Mar 26, 2025 |
| Dec 23, 2024 | $0.0027 | Dec 26, 2024 |
| Sep 23, 2024 | $0.0152 | Sep 25, 2024 |
| Jun 24, 2024 | $0.1148 | Jun 26, 2024 |
| Dec 18, 2023 | $0.0139 | Dec 21, 2023 |
1 month ago
-6.63%
Shares of vaccine and gene therapy stocks are trad...
Unlock content with
Pro Subscription
